Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42].

Spadaro G, Vultaggio A, Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2018 Apr;57:201. doi: 10.1016/j.intimp.2017.10.014. Epub 2017 Oct 28. No abstract available.

PMID:
29089244
2.

Health-Related Quality of Life and Patients' Empowerment in the Health Care of Primary Immune Deficiencies.

Quinti I, Pulvirenti F.

J Clin Immunol. 2017 Oct;37(7):615-616. doi: 10.1007/s10875-017-0428-0. Epub 2017 Aug 17. No abstract available.

3.

Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.

Jolles S, Sánchez-Ramón S, Quinti I, Soler-Palacín P, Agostini C, Florkin B, Couderc LJ, Brodszki N, Jones A, Longhurst H, Warnatz K, Haerynck F, Matucci A, de Vries E.

Clin Exp Immunol. 2017 Nov;190(2):226-234. doi: 10.1111/cei.13012. Epub 2017 Aug 25.

4.

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.

Quinti I, Mitrevski M.

Front Immunol. 2017 Jun 16;8:697. doi: 10.3389/fimmu.2017.00697. eCollection 2017.

5.

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement.

Cavaliere FM, Prezzo A, Bilotta C, Iacobini M, Quinti I.

PLoS One. 2017 Apr 19;12(4):e0175961. doi: 10.1371/journal.pone.0175961. eCollection 2017.

6.

Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.

Spadaro G, Vultaggio A, Alberto Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2017 Mar;44:38-42. doi: 10.1016/j.intimp.2016.12.030. Epub 2017 Jan 7. Erratum in: Int Immunopharmacol. 2018 Apr;57:201.

PMID:
28073042
7.

Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire.

Quinti I, Pulvirenti F, Giannantoni P, Hajjar J, Canter DL, Milito C, Abeni D, Orange JS, Tabolli S.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1169-1179.e4. doi: 10.1016/j.jaip.2016.07.012. Epub 2016 Sep 21.

8.

Reply.

Bonilla FA, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):1019-20. doi: 10.1016/j.jaip.2016.04.029. No abstract available.

9.

Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.

Danieli MG, Pulvirenti F, Rocchi V, Morariu R, Quinti I.

Immunotherapy. 2016 Sep;8(9):995-1002. doi: 10.2217/imt-2016-0035.

PMID:
27485073
10.

Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency.

Prezzo A, Cavaliere FM, Bilotta C, Iacobini M, Quinti I.

Cell Immunol. 2016 Aug-Sep;306-307:25-34. doi: 10.1016/j.cellimm.2016.05.006. Epub 2016 May 28.

PMID:
27264689
11.

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.

Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, Lucas CL, Matthews H, Deau MC, Sharapova S, Curtis J, Reichenbach J, Glastre C, Parry DA, Arumugakani G, McDermott E, Kilic SS, Yamashita M, Moshous D, Lamrini H, Otremba B, Gennery A, Coulter T, Quinti I, Stephan JL, Lougaris V, Brodszki N, Barlogis V, Asano T, Galicier L, Boutboul D, Nonoyama S, Cant A, Imai K, Picard C, Nejentsev S, Molina TJ, Lenardo M, Savic S, Cavazzana M, Fischer A, Durandy A, Kracker S.

J Allergy Clin Immunol. 2016 Jul;138(1):210-218.e9. doi: 10.1016/j.jaci.2016.03.022. Epub 2016 Apr 21.

12.

Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.

Pulvirenti F, Zuntini R, Milito C, Specchia F, Spadaro G, Danieli MG, Pession A, Quinti I, Ferrari S.

J Immunol Res. 2016;2016:8390356. doi: 10.1155/2016/8390356. Epub 2016 Mar 30.

13.

Otologic evaluation of patients with primary antibody deficiency.

Magliulo G, Iannella G, Granata G, Ciofalo A, Pasquariello B, Angeletti D, La Marra F, Quinti I.

Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3537-3546. Epub 2016 Mar 2.

PMID:
26935054
14.

Immunoglobulin-induced hemolysis, splenomegaly and inflammation in patients with antibody deficiencies.

Pulvirenti F, Granata G, Girelli G, Quinti I.

Expert Rev Clin Immunol. 2016 Jul;12(7):725-31. doi: 10.1586/1744666X.2016.1151787. Epub 2016 Mar 3. Review.

PMID:
26854522
15.

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, Espinosa-Rosales FJ, Hammarström L, Nonoyama S, Quinti I, Routes JM, Tang ML, Warnatz K.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):38-59. doi: 10.1016/j.jaip.2015.07.025. Epub 2015 Nov 7. No abstract available.

16.

Editorial: Immunoglobulin Therapy in the 21st Century - the Dark Side of the Moon.

Farrugia A, Visentini M, Quinti I.

Front Immunol. 2015 Aug 26;6:436. doi: 10.3389/fimmu.2015.00436. eCollection 2015. No abstract available.

17.

B cells from nuclear factor kB essential modulator deficient patients fail to differentiate to antibody secreting cells in response to TLR9 ligand.

Giardino G, Cirillo E, Gallo V, Esposito T, Fusco F, Conte MI, Quinti I, Ursini MV, Carsetti R, Pignata C.

Clin Immunol. 2015 Dec;161(2):131-5. doi: 10.1016/j.clim.2015.08.008. Epub 2015 Aug 22.

PMID:
26307434
18.

Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy.

Moschese V, Cavaliere FM, Graziani S, Bilotta C, Milito C, Chini L, Quinti I.

J Allergy Clin Immunol. 2016 Feb;137(2):617-9. doi: 10.1016/j.jaci.2015.06.014. Epub 2015 Jul 30. No abstract available.

PMID:
26233927
19.

Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies.

Cavaliere FM, Prezzo A, Conti V, Bilotta C, Pulvirenti F, Iacobini M, Quinti I.

Int Immunopharmacol. 2015 Sep;28(1):596-603. doi: 10.1016/j.intimp.2015.07.017. Epub 2015 Jul 28.

PMID:
26232049
20.

Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies.

Milito C, Pulvirenti F, Serra G, Valente M, Pesce AM, Granata G, Catalano C, Fraioli F, Quinti I.

J Clin Immunol. 2015 Jul;35(5):491-500. doi: 10.1007/s10875-015-0172-2. Epub 2015 Jun 12.

21.

Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia.

Leuzzi V, Micheli R, D'Agnano D, Molinaro A, Venturi T, Plebani A, Soresina A, Marini M, Ferremi Leali P, Quinti I, Pietrogrande MC, Finocchi A, Fazzi E, Chessa L, Magnani M.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e98. doi: 10.1212/NXI.0000000000000098. eCollection 2015 Jun.

22.

On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Späth PJ, Granata G, La Marra F, Kuijpers TW, Quinti I.

Front Immunol. 2015 Feb 5;6:11. doi: 10.3389/fimmu.2015.00011. eCollection 2015. Review.

23.

A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.

Clemente N, Boggio E, Gigliotti CL, Orilieri E, Cappellano G, Toth E, Valletti PA, Santoro C, Quinti I, Pignata C, Notarangelo LD, Dianzani C, Dianzani I, Ramenghi U, Dianzani U, Chiocchetti A.

Genes Immun. 2015 Mar;16(2):151-61. doi: 10.1038/gene.2014.74. Epub 2015 Jan 8.

24.

Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy.

Farrugia A, Quinti I.

Front Immunol. 2014 Dec 23;5:665. doi: 10.3389/fimmu.2014.00665. eCollection 2014. Review.

25.

Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Kerr J, Quinti I, Eibl M, Chapel H, Späth PJ, Sewell WA, Salama A, van Schaik IN, Kuijpers TW, Peter HH.

Front Immunol. 2014 Dec 12;5:629. doi: 10.3389/fimmu.2014.00629. eCollection 2014. Review.

26.

Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment.

Quinti I, Pulvirenti F, Milito C, Granata G, Giovannetti G, La Marra F, Pesce AM, Farrugia A, Coluzzi S, Girelli G.

Transfusion. 2015 May;55(5):1067-74. doi: 10.1111/trf.12939. Epub 2014 Dec 22.

PMID:
25532440
27.

Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies.

Tabolli S, Giannantoni P, Pulvirenti F, La Marra F, Granata G, Milito C, Quinti I.

Front Immunol. 2014 Nov 26;5:605. doi: 10.3389/fimmu.2014.00605. eCollection 2014.

28.

Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.

Mitrevski M, Marrapodi R, Camponeschi A, Lazzeri C, Todi L, Quinti I, Fiorilli M, Visentini M.

Immunol Res. 2014 Dec;60(2-3):330-8. doi: 10.1007/s12026-014-8599-8.

PMID:
25407649
29.

Autoimmune lymphoproliferative syndrome in pregnancy: a case of favorable mother-fetal outcome in a well-controlled disease.

Patti S, Perrone G, De Pratti V, Quinti I, Milito C, Brunelli R.

J Obstet Gynaecol Res. 2015 Mar;41(3):460-3. doi: 10.1111/jog.12556. Epub 2014 Oct 10.

PMID:
25302402
30.

Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies.

Milito C, Pulvirenti F, Pesce AM, Digiulio MA, Pandolfi F, Visentini M, Quinti I.

J Clin Immunol. 2014 Oct;34(7):813-9. doi: 10.1007/s10875-014-0081-9. Epub 2014 Jul 22.

31.

Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency.

Visentini M, Marrapodi R, Conti V, Mitrevski M, Camponeschi A, Lazzeri C, Carbonari M, Catizone A, Quinti I, Fiorilli M.

J Allergy Clin Immunol. 2014 Aug;134(2):401-10. doi: 10.1016/j.jaci.2014.03.017. Epub 2014 May 1.

PMID:
24792875
32.

Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.

Pulvirenti F, Pentassuglio I, Milito C, Valente M, De Santis A, Conti V, d'Amati G, Riggio O, Quinti I.

J Immunol Res. 2014;2014:672458. doi: 10.1155/2014/672458. Epub 2014 Mar 31.

33.

Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial.

Chessa L, Leuzzi V, Plebani A, Soresina A, Micheli R, D'Agnano D, Venturi T, Molinaro A, Fazzi E, Marini M, Ferremi Leali P, Quinti I, Cavaliere FM, Girelli G, Pietrogrande MC, Finocchi A, Tabolli S, Abeni D, Magnani M.

Orphanet J Rare Dis. 2014 Jan 9;9:5. doi: 10.1186/1750-1172-9-5.

34.

Anti-infective prophylaxis for primary immunodeficiencies: what is done in Italian Primary Immunodeficiency Network centers (IPINet) and review of the literature.

Moschese V, Martire B, Soresina A, Chini L, Graziani S, Monteferrario E, Bacchetta R, Cancrini C, Fiorilli M, Gambineri E, Pession A, Pignata C, Quinti I, Rondelli R, Rossi P, Ugazio AG, Plebani A, Pietrogrande MC.

J Biol Regul Homeost Agents. 2013 Oct-Dec;27(4):935-46. Review.

PMID:
24382174
35.

Polyvalent immunoglobulins: challenges and perspectives.

Quinti I, Coluzzi S, Pulvirenti F, Prezzo A, Girelli G.

Blood Transfus. 2013 Sep;11 Suppl 4:s40-4. doi: 10.2450/2013.008s. Review. No abstract available.

36.

Clinical use of polyvalent immunoglobulins.

Quinti I, Pesce AM, Bonanni L, Rubino C, Pulvirenti F, Milito C.

Blood Transfus. 2013 Sep;11 Suppl 4:s33-9. doi: 10.2450/2013.007s. Review. No abstract available.

37.

Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification.

Pandolfi F, Milito C, Conti V, Pagliari D, Frosali S, Cianci R, Quinti I.

J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2):285-9. Review.

PMID:
23830379
38.

Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients.

Wong GK, Goldacker S, Winterhalter C, Grimbacher B, Chapel H, Lucas M, Alecsandru D, McEwen D, Quinti I, Martini H, Milito C, Schmidt RE, Ernst D, Espanol T, Vidaller A, Carbone J, Fernandez-Cruz E, Lougaris V, Plebani A, Kutukculer N, Gonzalez-Granado LI, Contreras R, Kiani-Alikhan S, Ibrahim MA, Litzman J, Jones A, Gaspar HB, Hammarstrom L, Baumann U, Warnatz K, Huissoon AP; Clinical Working Party of the European Society for Immunodeficiencies (ESID).

Clin Exp Immunol. 2013 Apr;172(1):63-72. doi: 10.1111/cei.12039. Erratum in: Clin Exp Immunol. 2013 Jul;173(1):161. Milito, C [added].

39.

Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report.

De Nardo P, Bellagamba R, Corpolongo A, Gentilotti E, Taglietti F, Rosati S, Galeazzi M, Sebastiani GD, Quinti I, Nicastri E.

Clin Vaccine Immunol. 2013 May;20(5):761-4. doi: 10.1128/CVI.00081-13. Epub 2013 Mar 6.

40.

Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency.

Cavaliere FM, Milito C, Martini H, Schlesier M, Dräger R, Schütz K, Brunetti G, Pesce AM, Thon V, Warnatz K, Quinti I.

J Clin Immunol. 2013 May;33(4):838-46. doi: 10.1007/s10875-012-9856-z. Epub 2012 Dec 29.

PMID:
23274802
41.

Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects.

Schütz K, Hughes RG, Parker A, Quinti I, Thon V, Cavaliere M, Würfel M, Herzog W, Gessner JE, Baumann U.

J Clin Immunol. 2013 Jan;33(1):288-96. doi: 10.1007/s10875-012-9792-y. Epub 2012 Sep 25.

PMID:
23007236
42.

Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency.

Quinti I, Agostini C, Tabolli S, Brunetti G, Cinetto F, Pecoraro A, Spadaro G.

Blood. 2012 Aug 30;120(9):1953-4. doi: 10.1182/blood-2012-05-431064. No abstract available.

43.

Health related quality of life in common variable immunodeficiency.

Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, Baumghartner M, Colantuono S, Milito C, Tabolli S.

Yonsei Med J. 2012 May;53(3):603-10. doi: 10.3349/ymj.2012.53.3.603.

44.

Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.

Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, Plebani A, Lougaris V, Quinti I, Thon V, Litzman J, Schlesier M, Warnatz K, Thiel J, Rolink AG, Eibel H.

J Immunol. 2012 Jan 1;188(1):497-503. doi: 10.4049/jimmunol.1102321. Epub 2011 Nov 28.

45.

Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively.

Meunier JC, Bukh J, Diaz G, Tovo PA, Casadei AM, Quinti I, Iorio R, Emerson S, Purcell RH, Farci P.

J Infect Dis. 2011 Dec 1;204(11):1741-5. doi: 10.1093/infdis/jir631. Epub 2011 Oct 17.

46.

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study.

Borte M, Quinti I, Soresina A, Fernández-Cruz E, Ritchie B, Schmidt DS, McCusker C.

J Clin Immunol. 2011 Dec;31(6):952-61. doi: 10.1007/s10875-011-9588-5. Epub 2011 Sep 20.

PMID:
21932110
47.

Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity.

Serra G, Milito C, Mitrevski M, Granata G, Martini H, Pesce AM, Sfika I, Bonanni L, Catalano C, Fraioli F, Quinti I.

Chest. 2011 Dec;140(6):1581-1589. doi: 10.1378/chest.10-3147. Epub 2011 May 26.

PMID:
21622550
48.

Importance of B cell co-stimulation in CD4(+) T cell differentiation: X-linked agammaglobulinaemia, a human model.

Martini H, Enright V, Perro M, Workman S, Birmelin J, Giorda E, Quinti I, Lougaris V, Baronio M, Warnatz K, Grimbacher B.

Clin Exp Immunol. 2011 Jun;164(3):381-7. doi: 10.1111/j.1365-2249.2011.04377.x. Epub 2011 Apr 13.

49.

Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.

Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, Milito C, Trombetta AC, Visentini M, Martini H, Plebani A, Fiorilli M; IPINet Investigators.

J Clin Immunol. 2011 Jun;31(3):315-22. doi: 10.1007/s10875-011-9511-0. Epub 2011 Mar 2.

PMID:
21365217
50.

High prevalence of intestinal carriage of Campylobacter coli in patients with primary antibody deficiencies: a silent infection that could shift to a life-threatening condition.

Dionisi AM, Milito C, Martini H, Pesce AM, Mitrevski M, Granata G, Lucarelli C, Parisi A, Luzzi I, Quinti I.

J Clin Gastroenterol. 2011 May-Jun;45(5):474-5. doi: 10.1097/MCG.0b013e318206bdb8. No abstract available.

PMID:
21358549

Supplemental Content

Loading ...
Support Center